Omega-3 fatty acid ethyl esters - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Omega-3-acid ethyl ester medicines: dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors

Key facts

• Active substance:
  Omega-3 fatty acid ethyl esters
• Therapeutic area (MeSH):
  Cardiovascular Diseases
• Regulatory outcome:
  Variation
• DHPC type:
  Adverse event
• Dissemination date:
  08/11/2023